We report a case of subcutaneous infection in a 67 year-old Cambodian man who presented with a 5-month history of swelling of the right foot. Histopathology was compatible with phaeohyphomycosis and the hyphomycete Phialemoniopsis ocularis was identified by the means of morphological and molecular techniques. The patient responded well to a 6-month oral treatment with voriconazole alone.
Introduction
Phaeohyphomycoses are fungal infections defined by the presence of pigmented filaments in tissues [1, 2] . The clinical presentations of phaeohyphomycosis are mostly superficial, like subcutaneous abscesses or nodules which usually follow a trauma or skin injury [3] .
The number of reported phaeohyphomycosis seems to be in increasing over the past decades. According to the published cases, the species involved are diverse, although they mostly belong to the genera Exophiala, Alternaria, Phialophora, Curvularia and Fonsecaea [1] . However, new species have been more recently described [4] : we report here a rare case of a chronic subcutaneous phaeohyphomycosis of the right foot caused by Phialemoniopsis ocularis, formerly known as Sarcopodium oculorum. Since this species is often confused with Phialemonium or Lecythophora species [4] , we used phenotypic characteristics and nucleic acid sequences for its definite identification [4, 5] . The clinical outcome was satisfactory after a 6-month treatment with oral voriconazole alone.
Case
A 67 year-old Cambodian man, living in France for a little over a year, presented with a five month-history of a subcutaneous mass on the outer face of his right first toe (day 0 being the day of hospital admission). In his medical history, the existence of a noninsulin dependent diabetes and asymptomatic chronic infection with hepatitis B virus (HBV) were recorded. There was no known immunodeficiency, and the patient did not remember any trauma. The clinical examination revealed a large painless swelling of the first metatarsophalangeal joint, mimicking a bursitis as shown on MRI (Fig. 1) . After discussion in multidisciplinary staff, a skin biopsy was performed on day þ14. The presence of a pus collection surrounded by a fibrous shell led to the prescription of antibiotic treatment (amoxicillin -clavulanic acid 1 g/125 mg tid). At day þ15, the histopathological analysis of the skin biopsy 3E-F). The production of secondary conidia (repeated phialidic germination of the conidia) also occurred (Fig. 3G ). The discrete phialides were terminal or lateral and mostly monophialidic, but polyphialides were also observed: they were cylindrical to flaskshaped, and adelophialides were cylindrical or reduced to lateral collarettes on undifferentiated hyphae. Conidia were one-celled, hyaline to subhyaline, smooth-walled, slightly apiculate at base and aggregated in slimy heads. Two types of conidia were present: ellipsoidal to broadly ellipsoidal 5-6 Â 1.5-2 mm 2 , and allantoid with slightly apiculate base 3-5 Â 1-1.5 mm 2 . All these characteristics allowed us to identify the isolate as belonging to the genus Phialemoniopsis, despite that conidiomata were not observed. Molecular identification was ascertained by PCR amplification and sequencing of the ITS1-5.8S-ITS2 region, the D1-D2 domains of the ribosomal DNA and two fragments of the actin and tubulin genes [6] . The nucleotide sequence European Nucleotide Archive (ENA) accession numbers and the percentage of identity for each locus with the type strain of P. ocularis (IHEM 19077) were HG933293/98.8%, HG933292/ 100%, HG933291/98.3% and HG933290/99.2% respectively.
Antifungal susceptibility testing was assessed by broth microdilution EUCAST [7] method with some modifications. Briefly, testing of amphotericin B was performed on AM3 medium and MIC endpoints were determined on an automated microplate reader spectrophotometer [6, 7] . The minimal inhibitory concentrations (MICs) for amphotericin B, and echinocandins (caspofungin, micafungin, anidulafungin) were high (8 mg/ml) and much lower for azoles (voriconazole (0.25 mg/ml), posaconazole (0.5 mg/ml) and itraconazole (1 mg/ml)).
At day þ43, a treatment with voriconazole (V-Fend s , Pfizer, Paris, France) was initiated at a loading dose of 400 mg bid for 24 h, then at 200 mg per os every 12 h. The first clinical assessment after 1.5 month of treatment was satisfactory, except for the dorsal side of the foot, which was still erythematous (day þ85). Since drug monitoring previously showed a voriconazole overdosage in blood at day þ 75 (8 mg/L), the dose was divided by two at day þ85. The antifungal treatment was finally stopped after 6 months, at day þ246 (Fig. 4) . . The black arrowheads show the conspicuous collarettes, the solid black arrows exhibit the adelophialides. The white arrow points to a discrete phialide and the red asterisk to a phialide with two conidiogenic loci (polyphialide). (For interpretation of references to color in this figure legend, the reader is referred to the web version of this article.) Fig. 4 . Aspect of the right foot after 6 months of oral antifungal treatment with voriconazole. The initial lesion on the outer part of the hallux had almost disappeared. There was a good healing with no redness or pain. To note, the mycological exploration of the altered nail was not contributive.
Discussion
Phaeohyphomycoses include all superficial or deep infections caused by fungi -also named dematiaceous molds -that exhibit a filamentous growth within tissues [3, 8] , regardless of taxonomic classification or anatomical localization of lesions. One must distinguish them from two other clinical entities: chromoblastomycosis and eumycetoma [2] . Molds responsible for phaeohyphomycosis are cosmopolitan, but are mostly prevalent in the warm and humid climates of (sub-) tropical areas [9] . Although isolated species mainly belong to the genera Exophiala (including ex-Wangiella), Alternaria, Curvularia, Bipolaris, Exserohilum, Phoma, Phialemonium, and Phialophora, it is estimated that more than 70 genera and 130 species of dematiaceous fungi may cause phaeohyphomycosis [1] . Cutaneous and subcutaneous phaeohyphomycosis is usually secondary to direct inoculation, most often in the lower limbs (by trauma or skin penetration by a contaminated plant thorn/splinter) [1, 3] . In a chronic and painless course, phaeohyphomycosis begins with the appearance of small papules at the penetration point, and then evolves into a mobile cyst sometimes filled with pus. Ultimately, it results in the formation of nodules in relief or indurated plaques [1, 3] . In immunocompromised subjects, phaeohyphomycosis may become opportunistic, and potentially generates a disseminated or invasive infection that is associated with a very poor prognosis [4] .
The genus Phialemoniopsis has been recently erected to accommodate Phialemoniopsis curvata, formerly named Phialemo nium curvatum which was actually found to be phylogenetically far away from the type species of the genus Phialemonium, i.e. P. obovatum [5] . Although it exhibits morphological features similar to Phialemonium (and also to the genus Lecythophora) such as the presence of discrete phialides and adelophialides, the most distinctive character of the Phialemoniopsis species relies in the formation of picnidial or sporodochial-like conidiomata in culture. Although our specimen did not produce conidiomata structures in any agar media tested, groups of short and profusely branched conidiophores were observed on OA, which were similar to those forming in sporodochia. The loss of the ability to form conidiomata, and the production of the intermediate forms, was also noticed by Perdomo et al. [4, 5] . Besides, the genus Phialemoniopsis can be also differentiated from Phialemonium by the presence of conspicuous collarettes in the conidiogenous cells, and from Lecythophora because the colonies of the latter are slimy and usually pink or salmon colored. Furthermore, the analysis of the ITS, 28S region sequences and the D1/D2 domains of the ribosomal DNA, and two fragments of the actin and tubulin genes allowed us a reliable identification of the strain as P. ocularis, previously known as S. oculorum [4, 5] .
In addition to P. curvata and P. ocularis, the genus Phialemoniopsis also encompasses the species P. cornearis and P. pluriloculosa which have all been isolated from plants, decaying vegetables, sewage and water [4, 5] . Among the twenties human infections due to the genus Phialemoniopsis, the most were caused by the P. curvata species [4, 5] . They corresponded to localized forms, and to deep or disseminated mycoses like arthritis and fungemia respectively [4, [10] [11] [12] [13] [14] . To our knowledge, only one case of phaeohyphomycosis due to the species P. ocularis was correctly reported in the literature, since Guarro et al. described a corneal ulcer that occurred in a Brazilian boy [15] . The few other cases were retrospectively documented in collection by the means of amplification of the ITS, D1/D2, actin and β-tubulin sequences. These strains had been actually isolated in USA from peritoneal dialysis, left hand sampling and cellulitis aspirate, and formerly identified erroneously as Phialemonium sp. [5] .
Few recommendations are available about the treatment of phaeohyphomycosis. Some case series have highlighted the interest of total excision of the lesion, especially when it is single and easily accessible [2, 16] . In this specific context, the antifungal drug does not therefore seem essential. In case of incomplete resection or relapse, an adjunctive antifungal medication is thereafter indicated [2] : thus, oral itraconazole is still considered as the standard treatment [1, 17] . Besides, some authors attempted its association with terbinafine in Fonsecaea monophora infections, which likely resulted in a synergistic effect [18] . Likewise, intravenous amphotericin B was experienced before an oral relay with a triazole [19] . As demonstrated by our case, voriconazole nowadays appears to be a credible alternative for the management of phaeohyphomycosis [20] . Nevertheless, it is of course difficult to propose an optimal standard treatment for infections due to Phialemoniopsis spp., because of the lack of clinical data. The choice of the antifungal drug should be always based on the MICs assessed in vitro.
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